SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.32 CNY | +2.81% |
|
+0.81% | -10.83% |
| Jul. 01 | Shanghai Fosun Pharmaceutical Co., Ltd. Announces Board and Board Committee Changes | CI |
| Jun. 28 | Shanghai Fosun Pharmaceutical Gets Registration Application Approval for Chest Pain Drug | MT |
ETFs positioned on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.27% | 1 M€ | -23.55% | - | |
| 1.18% | 4 M€ | -2.96% | ||
| 0.12% | 35 M€ | -5.85% | - | |
| 0.09% | 2 M€ | -2.90% | - | |
| 0.07% | 4 M€ | -11.56% | ||
| 0.02% | 114 M€ | +7.37% | - | |
| 0.01% | 451 M€ | +9.23% | - | |
| 0.01% | 2,838 M€ | +12.11% | - | |
| 0.01% | 152 M€ | +9.69% | - | |
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 414 M€ | +12.33% | - | |
| 0.00% | 7 M€ | +5.72% | - | |
| 0.00% | 35 M€ | +6.70% | - | |
| 0.00% | 32 M€ | +4.91% | - | |
| 0.00% | 104 M€ | +5.76% | - | |
| 0.00% | 17 M€ | +3.51% | - | |
| 0.00% | 55 M€ | +2.06% | - | |
| 0.00% | 15 M€ | +24.45% | ||
| 0.00% | 8 M€ | +0.48% | - |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities:
- research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases;
- sale of medical equipments and diagnosis products (17.3%);
- medical and hospital services (10.5%);
- other (0.1%).
China accounts for 72.9% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
22.32
CNY
Average target price
28.61
CNY
Spread / Average Target
+28.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.83% | 7.26B | |
| +56.89% | 809B | |
| +39.52% | 624B | |
| -6.55% | 351B | |
| +7.92% | 289B | |
| +13.74% | 240B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 166B | |
| -2.57% | 157B |
- Stock Market
- Equities
- 600196 Stock
- ETFs Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
